These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19404394)

  • 41. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer.
    Cui F; Wang J; Chen D; Chen YJ
    Oncol Rep; 2011 Mar; 25(3):701-8. PubMed ID: 21174061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biology and plasticity of CD133+ hematopoietic stem cells.
    Handgretinger R; Gordon PR; Leimig T; Chen X; Buhring HJ; Niethammer D; Kuci S
    Ann N Y Acad Sci; 2003 May; 996():141-51. PubMed ID: 12799292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
    Srivastava VK; Nalbantoglu J
    Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bmi-1 is essential for the oncogenic potential in CD133(+) human laryngeal cancer cells.
    Wei X; He J; Wang J; Yang X; Ma B
    Tumour Biol; 2015 Nov; 36(11):8931-42. PubMed ID: 26081615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD133+CD44+ population efficiently enriches colon cancer initiating cells.
    Haraguchi N; Ohkuma M; Sakashita H; Matsuzaki S; Tanaka F; Mimori K; Kamohara Y; Inoue H; Mori M
    Ann Surg Oncol; 2008 Oct; 15(10):2927-33. PubMed ID: 18663533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.
    Tabu K; Kimura T; Sasai K; Wang L; Bizen N; Nishihara H; Taga T; Tanaka S
    Mol Cancer; 2010 Feb; 9():39. PubMed ID: 20167130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
    Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
    Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and characterization of cancer stem cells in ovarian yolk sac tumors.
    Suzuki S; Terauchi M; Umezu T; Kajiyama H; Shibata K; Nawa A; Kikkawa F
    Cancer Sci; 2010 Oct; 101(10):2179-85. PubMed ID: 20804503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Isolation and in vivo tumorigenicity assay of CD133+ side population cells from laryngeal cancer cell line].
    Wu CP; Zhou L; Xie M; Tao L; Zhang M; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):223-7. PubMed ID: 22805024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
    Kobayashi I; Takahashi F; Nurwidya F; Nara T; Hashimoto M; Murakami A; Yagishita S; Tajima K; Hidayat M; Shimada N; Suina K; Yoshioka Y; Sasaki S; Moriyama M; Moriyama H; Takahashi K
    Biochem Biophys Res Commun; 2016 Apr; 473(1):125-132. PubMed ID: 26996130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting the BRAF Signaling Pathway in CD133pos Cancer Stem Cells of Anaplastic Thyroid Carcinoma.
    Bozorg-Ghalati F; Hedayati M; Dianatpour M; Mosaffa N; Azizi F
    Asian Pac J Cancer Prev; 2019 May; 20(5):1353-1360. PubMed ID: 31127889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines.
    Qiang L; Yang Y; Ma YJ; Chen FH; Zhang LB; Liu W; Qi Q; Lu N; Tao L; Wang XT; You QD; Guo QL
    Cancer Lett; 2009 Jun; 279(1):13-21. PubMed ID: 19232461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties.
    Wu A; Oh S; Wiesner SM; Ericson K; Chen L; Hall WA; Champoux PE; Low WC; Ohlfest JR
    Stem Cells Dev; 2008 Feb; 17(1):173-84. PubMed ID: 18271701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV.
    Pressey JG; Haas MC; Pressey CS; Kelly VM; Parker JN; Gillespie GY; Friedman GK
    Pediatr Blood Cancer; 2013 Jan; 60(1):45-52. PubMed ID: 22408058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.
    Shmelkov SV; Butler JM; Hooper AT; Hormigo A; Kushner J; Milde T; St Clair R; Baljevic M; White I; Jin DK; Chadburn A; Murphy AJ; Valenzuela DM; Gale NW; Thurston G; Yancopoulos GD; D'Angelica M; Kemeny N; Lyden D; Rafii S
    J Clin Invest; 2008 Jun; 118(6):2111-20. PubMed ID: 18497886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and characterization of CD133 targeted aptamer-drug conjugates for precision therapy of anaplastic thyroid cancer.
    Ge MH; Zhu XH; Shao YM; Wang C; Huang P; Wang Y; Jiang Y; Maimaitiyiming Y; Chen E; Yang C; Naranmandura H
    Biomater Sci; 2021 Feb; 9(4):1313-1324. PubMed ID: 33350399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of Cancer Stem-Like Phenotype by Curcumin and Deguelin in CAL-62 Anaplastic Thyroid Cancer Cells.
    Kocdor MA; Cengiz H; Ates H; Kocdor H
    Anticancer Agents Med Chem; 2019; 19(15):1887-1898. PubMed ID: 31584382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
    Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
    World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
    Kanwal R; Shukla S; Walker E; Gupta S
    Cancer Lett; 2018 Aug; 430():25-33. PubMed ID: 29775627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.